With tariffs on patented pharmaceuticals and input materials set to take effect for all companies on Sept. 29, the lack of clarity about rules […] The...
GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.
Bacterial wilt, caused by the soil-borne pathogen Ralstonia solanacearum, is one of the most destructive plant diseases in the world, striking tomatoes, potatoes, bananas and hundreds...
Alongside decisions involving capacity expansion, officials at Samsung Biologics announced that the company is pursuing opportunities to broaden its portfolio and address an increasingly diverse range...
A ribbon-cutting ceremony to mark the opening is scheduled for 24 September, with company leadership, employees, partners and community leaders expected to attend. According to ABEC,...
Argonaut Manufacturing Services, a CDMO specializing in aseptic fill-finish for injectable biologics and other drugs, has sold its life sciences and diagnostics unit to the private...
Merck pursues new cancer combinations, prediction markets put pharma’s confidential information in focus and personalized cancer vaccines confront manufacturing hurdles.
A new study showed that a prgrammed lysis approach cut mechanical separation energy by over 50 percent at pilot scale, widening the range of bioalternatives that...
Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency. The post Smarter Cell Culture...
A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their services. The post Top 10 Contract...
Scan to Read